Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC
NCT03623737
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
248
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Squamous Cell Carcinoma
Chemoradiation
Interventions
DRUG:
neoadjuvant chemoradiation
Sponsor
National Taiwan University Hospital